EMREmerson Electric Co.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $1.86In line
- vs $1.85 expected on Nov 4
- Stock move on it
- +2.43%
- one session
- Typical move
- ±1.8%
- average over 2 reports
- Price
- $166.95
- −0.07% today · $81.7B cap
Past and upcoming reports
2
| Nov 4, 2026 | Sep 30, 2026 | Time not given | $1.85 | $1.86 | +2.43% |
| Aug 5, 2026 | Jun 30, 2026 | Time not given | $1.68 | Beat$1.71 | −1.22%2d |
After the report
Aug 5, 2026 report
This covers the Aug 5, 2026 report. The Nov 4, 2026 numbers are in the table above.
Emerson’s raised outlook and modest EPS beat support the automation thesis, but valuation and overbought momentum constrain upside.
Emerson reported fiscal-quarter EPS of $1.71 versus $1.68 estimated, raised its outlook, and traded at $158.23, up 0.84% on August 7.
Reported against expected
BeatReported EPS was $1.71 versus $1.68 estimated, a $0.03 or 1.79% beat for the quarter ended June 30, 2026.
Guidance
RaisedManagement raised its outlook. specific revenue and earnings guidance figures were not provided.
How the stock reacted
The post-earnings window data was unavailable. EMR rose 0.84% to $158.23 on August 7 from $156.91 previously.
What changed
EPS reached $1.71 versus $1.68 expected, while management raised its outlook for Emerson’s automation transition.
What the price now assumes
At $158.23 and 34.58 times trailing earnings, investors are crediting execution despite RSI of 74.17.
What it means for the business
Maintain a constructive bias. upgrade only if raised outlook conversion produces stronger revenue and earnings over the next 30. 90 days.
The next one to three months, as we saw it then
Better case40%
Raised outlook execution validates automation growth and supports continued earnings expansion beyond the 1.79% quarterly EPS beat.
Base case40%
The outlook remains achievable, but a 34.58 trailing P/E and RSI of 74.17 leave limited tolerance for merely in-line execution.
Worse case20%
Failure to translate the raised outlook into revenue and earnings could expose the valuation and weaken the automation-transition thesis.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.